• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021年腹膜后肉瘤的治疗

Retroperitoneal Sarcoma Care in 2021.

作者信息

Schmitz Erika, Nessim Carolyn

机构信息

Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.

Department of General Surgery, Division of Surgical Oncology, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.

出版信息

Cancers (Basel). 2022 Mar 2;14(5):1293. doi: 10.3390/cancers14051293.

DOI:10.3390/cancers14051293
PMID:35267600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8909774/
Abstract

Soft-tissue sarcomas are biologically heterogenous tumors arising from connective tissues with over 100 subtypes. Although sarcomas account for <1% of all adult malignancies, retroperitoneal sarcomas are a distinct subgroup accounting for <10% of all sarcomatous tumors. There have been considerable advancements in the understanding and treatment of retroperitoneal sarcoma in the last decade, with standard treatment consisting of upfront primary surgical resection. The evidence surrounding the addition of radiation therapy remains controversial. There remains no standard with regards to systemic therapy, including immunotherapy. Adjunctive therapy remains largely dictated by expert consensus and preferences at individual centers or participation in clinical trials. In this 2021 review, we detail the anatomical boundaries of the retroperitoneum, clinical characteristics, contemporary standard of care and well as recent advancements in retroperitoneal sarcoma care. Ongoing international collaborations are encouraged to advance our understanding of this complex disease.

摘要

软组织肉瘤是起源于结缔组织的生物学异质性肿瘤,有100多种亚型。虽然肉瘤在所有成人恶性肿瘤中占比不到1%,但腹膜后肉瘤是一个独特的亚组,占所有肉瘤性肿瘤的不到10%。在过去十年中,腹膜后肉瘤的认识和治疗有了相当大的进展,标准治疗包括 upfront 原发性手术切除。关于放疗的添加的证据仍然存在争议。关于包括免疫疗法在内的全身治疗,目前尚无标准。辅助治疗在很大程度上仍取决于各中心的专家共识和偏好或参与临床试验。在这篇2021年的综述中,我们详细阐述了腹膜后的解剖边界、临床特征、当代护理标准以及腹膜后肉瘤护理的最新进展。鼓励正在进行的国际合作,以增进我们对这种复杂疾病的了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb4/8909774/41b93649b412/cancers-14-01293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb4/8909774/b604eaf7b5e2/cancers-14-01293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb4/8909774/41b93649b412/cancers-14-01293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb4/8909774/b604eaf7b5e2/cancers-14-01293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb4/8909774/41b93649b412/cancers-14-01293-g002.jpg

相似文献

1
Retroperitoneal Sarcoma Care in 2021.2021年腹膜后肉瘤的治疗
Cancers (Basel). 2022 Mar 2;14(5):1293. doi: 10.3390/cancers14051293.
2
Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma.腹膜后软组织肉瘤的病理学新进展。
Curr Oncol. 2022 Sep 7;29(9):6400-6418. doi: 10.3390/curroncol29090504.
3
Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.成人软组织肉瘤:在个体化医学时代,组织亚型特异性管理的最新进展。
CA Cancer J Clin. 2020 May;70(3):200-229. doi: 10.3322/caac.21605. Epub 2020 Apr 10.
4
[A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].[1例罕见的伴有横纹肌母细胞分化的神经鞘肉瘤(恶性蝾螈瘤)]
Tumori. 2003 Jul-Aug;89(4 Suppl):246-50.
5
Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS).西班牙肉瘤研究小组(GEIS)对腹膜后肉瘤患者诊断与治疗的最新综述及临床建议
Cancers (Basel). 2023 Jun 15;15(12):3194. doi: 10.3390/cancers15123194.
6
Contemporary Management of Retroperitoneal Soft Tissue Sarcomas.腹膜后软组织肉瘤的当代治疗策略。
Curr Oncol Rep. 2015 Aug;17(8):39. doi: 10.1007/s11912-015-0462-0.
7
Retroperitoneal tumors: Review of diagnosis and management.腹膜后肿瘤:诊断与治疗综述。
Int J Urol. 2020 Dec;27(12):1058-1070. doi: 10.1111/iju.14361. Epub 2020 Sep 10.
8
Retroperitoneal Sarcomas: An Update on the Diagnostic Pathology Approach.腹膜后肉瘤:诊断病理学方法的最新进展
Diagnostics (Basel). 2020 Aug 27;10(9):642. doi: 10.3390/diagnostics10090642.
9
Soft Tissue Tumors of the Abdomen and Retroperitoneum.腹部和腹膜后软组织肿瘤。
Surg Clin North Am. 2020 Jun;100(3):649-667. doi: 10.1016/j.suc.2020.02.011. Epub 2020 Apr 15.
10
Soft tissue sarcomas of the extremity and retroperitoneum: advances in management.四肢及腹膜后软组织肉瘤:治疗进展
Adv Surg. 1991;24:333-59.

引用本文的文献

1
Pancreatic liposarcoma: A case series and literature overview of an extremely rare soft tissue tumor.胰腺脂肪肉瘤:一个极其罕见的软组织肿瘤的病例系列及文献综述
Int J Surg Case Rep. 2025 Jul 18;134:111699. doi: 10.1016/j.ijscr.2025.111699.
2
Unusual Retroperitoneal Soft Tissue Sarcomas: Giant Masqueraders.不寻常的腹膜后软组织肉瘤:巨大的伪装者。
Niger Med J. 2025 Jun 16;66(2):783-790. doi: 10.71480/nmj.v66i2.618. eCollection 2025 Mar-Apr.
3
Perioperative Systemic Therapy in Rare, Chemosensitive Subtypes of Retroperitoneal Sarcoma: A Hospital-Based Propensity Score-Matched Analysis.

本文引用的文献

1
Incidence, Treatment and Outcome of Patients with Retroperitoneal Soft-Tissue Sarcoma in Switzerland 2005-2015: A Population-Based Analysis.2005-2015 年瑞士腹膜后软组织肉瘤患者的发病率、治疗和转归:一项基于人群的分析。
World J Surg. 2022 Feb;46(2):461-468. doi: 10.1007/s00268-021-06374-z. Epub 2021 Nov 9.
2
Postnephrectomy outcomes following en bloc resection of primary retroperitoneal sarcoma: multicentre study.原发性腹膜后肉瘤整块切除术后肾切除的结果:多中心研究
Br J Surg. 2022 Feb 1;109(2):165-168. doi: 10.1093/bjs/znab355.
3
Racial and ethnic differences in abdominal soft tissue sarcoma incidence in New Zealand: a retrospective audit.
罕见的化疗敏感型腹膜后肉瘤围手术期全身治疗:一项基于医院的倾向评分匹配分析
Cancers (Basel). 2025 Jun 10;17(12):1931. doi: 10.3390/cancers17121931.
4
A New ROCK Band for Diaphragmatic Reconstruction in Retroperitoneal Sarcoma Surgery.用于腹膜后肉瘤手术中膈肌重建的新型ROCK带。
J Surg Oncol. 2025 May;131(6):1196-1201. doi: 10.1002/jso.28111. Epub 2025 Mar 28.
5
Dedifferentiated liposarcoma with extensive cystic change causing significant diagnostic challenges: report of two cases and review of the literature.伴有广泛囊性变的去分化脂肪肉瘤带来显著诊断挑战:两例报告及文献复习
Diagn Pathol. 2025 Feb 27;20(1):23. doi: 10.1186/s13000-025-01619-0.
6
Metastatic dedifferentiated liposarcoma of the mediastinum with osteosarcomatous differentiation: A case report.纵隔转移性去分化脂肪肉瘤伴骨肉瘤分化:一例报告。
Medicine (Baltimore). 2024 Dec 6;103(49):e40748. doi: 10.1097/MD.0000000000040748.
7
Comprehensive treatment strategy for improving surgical resection rate of retroperitoneal sarcomas: a histology-specific approach narrative review.提高腹膜后肉瘤手术切除率的综合治疗策略:组织学特异性方法的叙述性综述
Front Oncol. 2024 Oct 7;14:1432900. doi: 10.3389/fonc.2024.1432900. eCollection 2024.
8
Leiomyosarcoma of the abdomen and retroperitoneum; a systematic review.腹部和腹膜后平滑肌肉瘤;一项系统综述
Front Surg. 2024 Jul 17;11:1375483. doi: 10.3389/fsurg.2024.1375483. eCollection 2024.
9
Surgical outcomes of major vascular resection for retroperitoneal liposarcoma from a high‑volume sarcoma center: a propensity score matching analysis.高容量肉瘤中心腹膜后脂肪肉瘤的主要血管切除的手术结果:倾向评分匹配分析。
J Cancer Res Clin Oncol. 2024 Jul 9;150(7):343. doi: 10.1007/s00432-024-05871-7.
10
Retroperitoneal Sarcoma Requiring Abdominal Aortic Replacement With Long-Term Survival: A Case Report.需要进行腹主动脉置换并长期存活的腹膜后肉瘤:一例报告
Cureus. 2024 May 13;16(5):e60198. doi: 10.7759/cureus.60198. eCollection 2024 May.
新西兰腹部软组织肉瘤发病率的种族和民族差异:一项回顾性审计。
ANZ J Surg. 2022 Jan;92(1-2):162-166. doi: 10.1111/ans.17310. Epub 2021 Oct 26.
4
Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis.腹膜后肉瘤的辅助治疗:一项荟萃分析。
Radiat Oncol. 2021 Oct 7;16(1):196. doi: 10.1186/s13014-021-01774-w.
5
Ischaemic colitis secondary to retroperitoneal liposarcoma.腹膜后脂肪肉瘤继发缺血性结肠炎。
BMJ Case Rep. 2021 Sep 29;14(9):e245595. doi: 10.1136/bcr-2021-245595.
6
Clinical biomarkers in soft tissue sarcoma A comprehensive review of current soft tissue sarcoma biomarkers.软组织肉瘤的临床生物标志物:软组织肉瘤生物标志物的综合综述。
J Surg Oncol. 2022 Feb;125(2):239-245. doi: 10.1002/jso.26680. Epub 2021 Sep 29.
7
18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma.18F-氟脱氧葡萄糖正电子发射断层扫描在评估腹膜后肉瘤预后中具有重要作用。
Cancers (Basel). 2021 Sep 14;13(18):4611. doi: 10.3390/cancers13184611.
8
Prognostic implications of histological organ involvement in retroperitoneal sarcoma.腹膜后肉瘤组织器官受累对预后的影响。
BJS Open. 2021 Sep 6;5(5). doi: 10.1093/bjsopen/zrab080.
9
Surgical and oncologic outcomes following arterial resection and reconstruction for advanced solid tumors.动脉切除和重建治疗晚期实体瘤的手术和肿瘤学结果。
J Surg Oncol. 2021 Dec;124(8):1251-1260. doi: 10.1002/jso.26665. Epub 2021 Sep 8.
10
Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma.预测手术切除后腹膜后脂肪肉瘤无复发生存的列线图的开发与验证
Cancer Manag Res. 2021 Aug 24;13:6633-6639. doi: 10.2147/CMAR.S321324. eCollection 2021.